• Focusing on the diagnosis and treatment of difficult and severe Hematologic Diseases such as leukemia, lymphoma, multiple myeloma, and thalassemia.
• Providing accurate diagnosis and individualized treatment. Individualizing the diagnosis and treatment plan for each patient by an effective combination of chemotherapy, radiotherapy, immunotherapy, targeted therapy, hematopoietic stem cell transplant and other technologies.
• Expanding the clinical application and research of CAR-T, innovative drugs and other advanced technologies to obtain more treatment options for refractory and relapsed patients.
• Safeguarding the whole treatment period for patients through efficient collaboration of the multidisciplinary team.

View

• Focusing on the diagnosis and treatment of solid tumors such as gastrointestinal tumors, lung tumors, bone and soft tissue sarcomas, hepatobiliary and pancreatic tumors, and breast tumors.
• Integrated diagnosis and treatment and one-stop service covering the diagnosis, medicine, surgery, radiotherapy, and interventional procedure.
• Multidisciplinary care(MDC), individualizing exclusive treatment and care plans for each patient.
• Several frontier molecular targeted drugs along with immunotherapy and clinical studies of new anti-tumor drugs provide new treatment options for refractory and relapsed patients.

View

Patient-centered and guided by clinical needs, the GoBroad team has created a patient-driven Multidisciplinary Care(MDC) model for interdisciplinary and all-around discussion and research on the conditions and nursing measures for patients with difficult, complex, and critical tumors. This approach effectively integrates conventional therapies with innovative diagnostic and treatment technologies, enabling patients to receive more advanced, personalized, and scientifically cutting-edge treatments in a comfortable setting. It not only offers them greater chances of recovery but also enhances their quality of life significantly.

View